Osan-si, South Korea

Ik-Su Jo


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ik-Su Jo

Introduction

Ik-Su Jo is a notable inventor based in Osan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing important chemical compounds. His work has implications for the production of medications that are vital for various health conditions.

Latest Patents

Ik-Su Jo holds a patent for "Processes for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine or a salt thereof and processes for preparing tofacitinib using the same." This patent outlines a method for creating an intermediate compound that is essential for the synthesis of tofacitinib, a medication used to treat autoimmune diseases. The patent emphasizes the stability of the intermediate compounds, which enhances the efficiency of the drug preparation process.

Career Highlights

Ik-Su Jo is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His role at Yuhan Corporation allows him to leverage his expertise in chemical processes to contribute to the development of innovative pharmaceutical solutions. His work is characterized by a commitment to advancing medical science through innovative chemical engineering.

Collaborations

Ik-Su Jo has collaborated with notable colleagues, including Sang-Ho Oh and Doo-Byung Lee. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical processes and products.

Conclusion

Ik-Su Jo's contributions to the field of pharmaceuticals through his innovative patent and work at Yuhan Corporation highlight his importance as an inventor. His dedication to improving drug synthesis processes is paving the way for more effective treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…